no statement of use filed
on 08 Jan 2024
Last Applicant/ Owned by
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
Serial Number
88752698 filed on 09th Jan 2020
Registration Number
N/A
Correspondent Address
Gene K. Park
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Syringes for pharmaceutical preparations; Injectors for pharmaceutical preparations; Syringes for medical purposes Pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Pharmaceutical preparations, namely, narcotic antagonists; Pharmaceutical preparations, nRead More
Syringes for pharmaceutical preparations; Injectors for pharmaceutical preparations; Syringes for medical purposes
Pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Pharmaceutical preparations, namely, narcotic antagonists; Pharmaceutical preparations, namely, opioid antagonists; Syringes sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Syringes sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Syringes sold filled with narcotic antagonists; Syringes sold filled with opioid antagonists; Injectors sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Injectors sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Injectors sold filled with narcotic antagonists; Injectors sold filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose and addiction; Injectable pharmaceuticals for use in the treatment of substance abuse disorders, addiction, and overdose; Injectable pharmaceuticals, namely, narcotic antagonists; Injectable pharmaceuticals, namely, opioid antagonists
No 88752698
No Service/Collective Mark
No 063995-0013
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 08th Jan 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| 08th Jan 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 07th Jun 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 06th Jun 2023 | SOU EXTENSION 5 GRANTED |
| 02th Jun 2023 | SOU TEAS EXTENSION RECEIVED |
| 02th Jun 2023 | SOU EXTENSION 5 FILED |
| 22nd Apr 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 21st Apr 2023 | SOU EXTENSION 4 GRANTED |
| 20th Apr 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 02th Mar 2023 | NOTICE OF REVIVAL - E-MAILED |
